# HARS2

## Overview
The HARS2 gene encodes the mitochondrial enzyme histidyl-tRNA synthetase 2, which plays a crucial role in mitochondrial protein synthesis by catalyzing the aminoacylation of tRNA His. This enzyme is essential for the translation of mitochondrial mRNA into functional proteins, a process vital for maintaining mitochondrial function and energy production (Gong2020Overexpression). Located on chromosome 5, the HARS2 gene comprises 13 exons and produces a protein that is 506 amino acids in length (Schwenzer2013Pathogenic; Whatley2020Usher). The protein is categorized as an aminoacyl-tRNA synthetase, a class of enzymes critical for protein biosynthesis. Mutations in HARS2 have been linked to Perrault syndrome, a condition characterized by sensorineural hearing loss and ovarian dysgenesis, highlighting the gene's clinical significance (Pierce2011Mutations; Konovalova2013Mitochondrial).

## Structure
The HARS2 gene encodes the mitochondrial histidyl-tRNA synthetase, which is involved in the aminoacylation of tRNA His, a critical step in mitochondrial protein synthesis (Gong2020Overexpression). The protein is 506 amino acids long and is encoded by a gene located on chromosome 5, consisting of 13 exons (Schwenzer2013Pathogenic; Whatley2020Usher).

The primary structure of HARS2 includes specific amino acid sequences that are crucial for its function. The secondary structure features α-helices and β-strands, with mutations such as Leu200Val and Val368Leu located in an α-helix, affecting the protein's structural stability (Datt2014Evolutionary). The tertiary structure forms a three-dimensional shape essential for its enzymatic activity, with the Leu200Val mutation situated in the catalytic domain and Val368Leu at the junction of the Rossmann fold domain and the loop connecting the C-terminal domain (Datt2014Evolutionary).

HARS2 may form a quaternary structure by interacting with other proteins, as suggested by the impact of mutations on dimer formation and enzymatic activity (Datt2014Evolutionary). The protein's structural integrity is crucial for its function, and mutations can lead to diseases such as Perrault syndrome (Schwenzer2013Pathogenic).

## Function
The HARS2 gene encodes the mitochondrial histidyl-tRNA synthetase, an enzyme essential for mitochondrial protein synthesis. This enzyme is responsible for the aminoacylation of tRNA His, a critical step in translating mitochondrial mRNA into functional proteins. By attaching histidine to its corresponding tRNA, HARS2 ensures the fidelity of mitochondrial translation, which is crucial for maintaining mitochondrial function and energy production (Gong2020Overexpression).

HARS2 localizes exclusively to mitochondria, as demonstrated by immunofluorescence studies, highlighting its specific role in mitochondrial processes (Gong2020Overexpression). The enzyme's activity is vital for the proper functioning of the mitochondrial respiratory chain, as it supports the synthesis of proteins required for oxidative phosphorylation. This process is essential for ATP production, which is the primary energy currency of the cell (Gong2020Overexpression).

Mutations in HARS2 can lead to mitochondrial dysfunction, affecting cellular energy metabolism and contributing to diseases such as Perrault syndrome, characterized by sensorineural hearing loss and ovarian dysgenesis (Konovalova2013Mitochondrial). The enzyme's role in maintaining mitochondrial health underscores its importance in cellular and organismal homeostasis.

## Clinical Significance
Mutations in the HARS2 gene are associated with Perrault syndrome, a rare genetic disorder characterized by sensorineural hearing loss and ovarian dysgenesis in females. This syndrome is autosomal recessive and can present with varying clinical features, including bilateral sensorineural hearing loss and primary ovarian insufficiency, potentially leading to infertility (Pierce2011Mutations; Yu2020Two). Specific mutations, such as c.598C > G (p.L200V) and c.1102G > T (p.V368L), have been identified as causative factors for Perrault syndrome, affecting the enzyme's activity and dimerization, with p.V368L showing more severe effects (Pierce2011Mutations).

In addition to Perrault syndrome, HARS2 mutations have been linked to non-syndromic hearing impairment (NSHI). Novel pathogenic variants, such as c.475C>T (p.Arg159*) and c.1439G>A (p.Arg480His), have been identified in families with NSHI, indicating the gene's role in hearing loss without other clinical signs (DomínguezRuiz2024Novel). Overexpression of HARS2 has been shown to correct mitochondrial dysfunctions associated with deafness-related tRNA mutations, suggesting a potential therapeutic approach for hearing loss linked to mitochondrial dysfunction (Gong2020Overexpression).

## Interactions
HARS2, the mitochondrial histidyl-tRNA synthetase, is involved in several critical interactions essential for its function. It primarily functions as a homodimer, with the dimer interface being crucial for its enzymatic activity. The variant HARS2 p.(Arg138His) is located in this dimer interface region, and its substitution may disrupt dimer formation and active site configuration, potentially affecting protein function (Demain2019A). 

HARS2 also interacts with mitochondrial tRNA His, facilitating its aminoacylation. Overexpression of HARS2 has been shown to enhance the aminoacylation levels of tRNA His, suggesting a direct interaction that is crucial for mitochondrial translation and function (Gong2020Overexpression). 

Mutations in HARS2, such as p.V368L, have been associated with altered protein-protein interactions, enhancing homodimerization compared to the wild-type protein. This mutation affects the protein's activity and interactions, indicating that HARS2's dimerization properties are sensitive to specific amino acid changes (Pierce2011Mutations). 

In the context of mitochondrial dysfunction, HARS2 has been observed to accumulate in mitochondria and relocate to the nucleus in certain pathological conditions, although the specific interactions in the nucleus remain unclear (Key2022CLPP).


## References


[1. (Demain2019A) Leigh A. M. Demain, Erica. H. Gerkes, Richard J. H. Smith, Leslie P. Molina-Ramirez, Raymond T. O’Keefe, and William G. Newman. A recurrent missense variant in hars2 results in variable sensorineural hearing loss in three unrelated families. Journal of Human Genetics, 65(3):305–311, December 2019. URL: http://dx.doi.org/10.1038/s10038-019-0706-1, doi:10.1038/s10038-019-0706-1. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s10038-019-0706-1)

[2. (Whatley2020Usher) Meg Whatley, Abbie Francis, Zi Ying Ng, Xin Ee Khoh, Marcus D. Atlas, Rodney J. Dilley, and Elaine Y. M. Wong. Usher syndrome: genetics and molecular links of hearing loss and directions for therapy. Frontiers in Genetics, October 2020. URL: http://dx.doi.org/10.3389/fgene.2020.565216, doi:10.3389/fgene.2020.565216. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2020.565216)

[3. (Key2022CLPP) Jana Key, Suzana Gispert, Lieke Koornneef, Esther Sleddens-Linkels, Aneesha Kohli, Sylvia Torres-Odio, Gabriele Koepf, Shady Amr, Marina Reichlmeir, Patrick N. Harter, Andrew Phillip West, Christian Münch, Willy M. Baarends, and Georg Auburger. Clpp depletion causes diplotene arrest; underlying testis mitochondrial dysfunction occurs with accumulation of perrault proteins eral1, peo1, and hars2. Cells, 12(1):52, December 2022. URL: http://dx.doi.org/10.3390/cells12010052, doi:10.3390/cells12010052. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells12010052)

[4. (Gong2020Overexpression) Shasha Gong, Xiaoqiong Wang, Feilong Meng, Limei Cui, Qiuzi Yi, Qiong Zhao, Xiaohui Cang, Zhiyi Cai, Jun Qin Mo, Yong Liang, and Min-Xin Guan. Overexpression of mitochondrial histidyl-trna synthetase restores mitochondrial dysfunction caused by a deafness-associated trnahis mutation. Journal of Biological Chemistry, 295(4):940–954, January 2020. URL: http://dx.doi.org/10.1016/s0021-9258(17)49906-6, doi:10.1016/s0021-9258(17)49906-6. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0021-9258(17)49906-6)

[5. (Schwenzer2013Pathogenic) Hagen Schwenzer, Joffrey Zoll, Catherine Florentz, and Marie Sissler. Pathogenic Implications of Human Mitochondrial Aminoacyl-tRNA Synthetases, pages 247–292. Springer Netherlands, 2013. URL: http://dx.doi.org/10.1007/128_2013_457, doi:10.1007/128_2013_457. This article has 21 citations.](https://doi.org/10.1007/128_2013_457)

[6. (Yu2020Two) Jing Yu, Wei Jiang, Li Cao, Xiaoxue Na, and Jiyun Yang. Two novel likely pathogenic variants of hars2 identified in a chinese family with sensorineural hearing loss. Hereditas, November 2020. URL: http://dx.doi.org/10.1186/s41065-020-00157-7, doi:10.1186/s41065-020-00157-7. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s41065-020-00157-7)

[7. (Datt2014Evolutionary) Manish Datt and Amit Sharma. Evolutionary and structural annotation of disease-associated mutations in human aminoacyl-trna synthetases. BMC Genomics, 15(1):1063, 2014. URL: http://dx.doi.org/10.1186/1471-2164-15-1063, doi:10.1186/1471-2164-15-1063. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-15-1063)

[8. (DomínguezRuiz2024Novel) María Domínguez-Ruiz, Margarita Olarte, Esther Onecha, Irene García-Vaquero, Nancy Gelvez, Greizy López, Manuela Villamar, Matías Morín, Miguel A. Moreno-Pelayo, Carmelo Morales-Angulo, Rubén Polo, Martha L. Tamayo, and Ignacio del Castillo. Novel cases of non-syndromic hearing impairment caused by pathogenic variants in genes encoding mitochondrial aminoacyl-trna synthetases. Genes, 15(7):951, July 2024. URL: http://dx.doi.org/10.3390/genes15070951, doi:10.3390/genes15070951. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes15070951)

[9. (Pierce2011Mutations) Sarah B. Pierce, Karen M. Chisholm, Eric D. Lynch, Ming K. Lee, Tom Walsh, John M. Opitz, Weiqing Li, Rachel E. Klevit, and Mary-Claire King. Mutations in mitochondrial histidyl trna synthetase hars2 cause ovarian dysgenesis and sensorineural hearing loss of perrault syndrome. Proceedings of the National Academy of Sciences, 108(16):6543–6548, April 2011. URL: http://dx.doi.org/10.1073/pnas.1103471108, doi:10.1073/pnas.1103471108. This article has 207 citations.](https://doi.org/10.1073/pnas.1103471108)

[10. (Konovalova2013Mitochondrial) Svetlana Konovalova and Henna Tyynismaa. Mitochondrial aminoacyl-trna synthetases in human disease. Molecular Genetics and Metabolism, 108(4):206–211, April 2013. URL: http://dx.doi.org/10.1016/j.ymgme.2013.01.010, doi:10.1016/j.ymgme.2013.01.010. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ymgme.2013.01.010)